Checkpoint Capital L.P. Spring Works Therapeutics, Inc. Transaction History
Checkpoint Capital L.P.
- $202 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
240Shares Held
69.7MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$270 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$226 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$155 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$142 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$138 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.51B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...